Eli Lilly (LLY) has agreed to acquire Adverum Biotechnologies (ADVM), which is developing a therapy
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Eli Lilly to Acquire Eye Gene Therapy Developer Adverum Biotechnologies
Published 2 weeks ago
Oct 24, 2025 at 3:14 PM
Positive
Auto